Inseok Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Inseok Park has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Byung-Noe Bae
Department of Surgery, Inje University Sanggye Paik Hospital, Seoul, Korea
2 shared publications Jungbin Kim
Department of Surgery, Inje University Sanggye Paik Hospital, Seoul, Korea
2 shared publications- Keunho Yang
Department of Surgery, InJe University Sanggye Paik Hospital, InJe University College of medicine, Seoul, South Korea
2 shared publications - Bomi Kim
Department of General Surgery, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
1 shared publication Byung Noe Bae
Department of Surgery, Inje University Sanggye Paik Hospital, Seoul, Korea
1 shared publication- Chansub Park
Department of Surgery, Sanggye Paik Hospital, College of Medicine, Inje University, 1342 Dongil-ro, Nowon-gu, Seoul, 139-707, Korea
1 shared publication
Latest Publications
- Open Access
- 31 August 2020
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 36 (4) , 223-228
Factors Predicting the Need for Early Surgical Intervention for Small Bowel Obstruction
Purpose: Small bowel obstruction (SBO) is a common disease that requires hospitalization. The most common cause of SBO is postoperative adhesion. Delayed timing of operations in patients who need surgical intervention results in mortality or morbidity. A number of studies on SBO have established criteria for emergency surgery. However, few objective clinical parameters are available for screening patients who need a delayed operation. Therefore, we analyzed factors that affect the clinical course of SBO to select appropriate therapeutic plans for reducing the risk of complications in these patients.Methods: We investigated the clinical characteristics of patients admitted to the surgery department of our hospital between January 1, 2015, and December 31, 2016, who were diagnosed with SBO. Patients were divided into an operative treatment group (n = 12) and a conservative treatment group (n = 96). We compared clinical characteristics between the 2 groups.Results: The operative treatment group underwent more operations before SBO than the conservative treatment group (P = 0.007). Initial leukocyte counts (P = 0.004) and C-reactive protein (CRP) levels (P = 0.028) were elevated in the operative group. Body mass index (BMI) was lower in the operative group (P = 0.013).Conclusion: The number of operations before SBO, leukocyte counts, CRP levels, and BMI were useful parameters for selecting patients who needed an urgent operation for SBO.
- 31 August 2020
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 36 (4) , 223-228
Open AccessFactors Predicting the Need for Early Surgical Intervention for Small Bowel Obstruction
Purpose: Small bowel obstruction (SBO) is a common disease that requires hospitalization. The most common cause of SBO is postoperative adhesion. Delayed timing of operations in patients who need surgical intervention results in mortality or morbidity. A number of studies on SBO have established criteria for emergency surgery. However, few objective clinical parameters are available for screening patients who need a delayed operation. Therefore, we analyzed factors that affect the clinical course of SBO to select appropriate therapeutic plans for reducing the risk of complications in these patients.Methods: We investigated the clinical characteristics of patients admitted to the surgery department of our hospital between January 1, 2015, and December 31, 2016, who were diagnosed with SBO. Patients were divided into an operative treatment group (n = 12) and a conservative treatment group (n = 96). We compared clinical characteristics between the 2 groups.Results: The operative treatment group underwent more operations before SBO than the conservative treatment group (P = 0.007). Initial leukocyte counts (P = 0.004) and C-reactive protein (CRP) levels (P = 0.028) were elevated in the operative group. Body mass index (BMI) was lower in the operative group (P = 0.013).Conclusion: The number of operations before SBO, leukocyte counts, CRP levels, and BMI were useful parameters for selecting patients who needed an urgent operation for SBO.
- Open Access
- 15 March 2020
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 23 (1) , 43-48
Unmodifiable Clinicopathological Risk Factors of Shoulder Tip or Subcostal Pain after Laparoscopic Appendectomy
Bomi Kim, M.D., Jungbin Kim, M.D., Inseok Park, M.D., Hyunjin Cho, M.D., Geumhee Gwak, Ph.D., Keun Ho Yang, Ph.D., Byung-Noe Bae, Ph.D., Kihwan Kim, Ph.D.. Journal of Minimally Invasive Surgery 2020;23:43-8. https://doi.org/10.7602/jmis.2020.23.1.43
- 15 March 2020
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 23 (1) , 43-48
Open AccessUnmodifiable Clinicopathological Risk Factors of Shoulder Tip or Subcostal Pain after Laparoscopic Appendectomy
Bomi Kim, M.D., Jungbin Kim, M.D., Inseok Park, M.D., Hyunjin Cho, M.D., Geumhee Gwak, Ph.D., Keun Ho Yang, Ph.D., Byung-Noe Bae, Ph.D., Kihwan Kim, Ph.D.. Journal of Minimally Invasive Surgery 2020;23:43-8. https://doi.org/10.7602/jmis.2020.23.1.43
- Open Access
- 1 January 2020
- Published by Elsevier in Asian Journal of Surgery
- Vol. 43 (1) , 193-200
Factors affecting the negative predictive value of positron emission tomography/computed tomography for axillary lymph node staging in breast cancer patients
- 1 January 2020
- Published by Elsevier in Asian Journal of Surgery
- Vol. 43 (1) , 193-200
Open AccessFactors affecting the negative predictive value of positron emission tomography/computed tomography for axillary lymph node staging in breast cancer patients
- Open Access
- 13 September 2016
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 244
Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressive clinical features. We investigated the clinical implications of single hormone receptor negativity in a luminal B HER2-negative group. We collected luminal B HER2-negative breast cancer data that were estrogen receptor (ER) and/or progesterone receptor (PR) positive, Ki 67 high (>14 %), and HER2 negative and divided them into the ER- and PR-positive group and the ER- or PR-negative group. We analyzed the clinical and pathological data and survival according to ER or PR loss. There were no statistical differences in TNM stage, breast and axillary operative methods, or number of tumors between the ER- and PR-positive group and ER- or PR-negative group. However, the ER- or PR-negative group was associated with older age (≥45 years), higher histological grade, lower Bcl-2 expression, and far higher Ki 67 (>50 %). Disease-free survival (DFS) and overall survival (OS) were shorter in the ER- or PR-negative group than that in the ER- and PR-positive group (p = 0.0038, p = 0.0071). ER- or PR-negative subgroup showed worse prognosis than ER- and PR-positive subgroup in the luminal B HER2-negative group. We could consider the negativity of ER or PR as prognostic marker in luminal B HER2-negative subtype of breast cancer.
- 13 September 2016
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 244
Open AccessPrognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressive clinical features. We investigated the clinical implications of single hormone receptor negativity in a luminal B HER2-negative group. We collected luminal B HER2-negative breast cancer data that were estrogen receptor (ER) and/or progesterone receptor (PR) positive, Ki 67 high (>14 %), and HER2 negative and divided them into the ER- and PR-positive group and the ER- or PR-negative group. We analyzed the clinical and pathological data and survival according to ER or PR loss. There were no statistical differences in TNM stage, breast and axillary operative methods, or number of tumors between the ER- and PR-positive group and ER- or PR-negative group. However, the ER- or PR-negative group was associated with older age (≥45 years), higher histological grade, lower Bcl-2 expression, and far higher Ki 67 (>50 %). Disease-free survival (DFS) and overall survival (OS) were shorter in the ER- or PR-negative group than that in the ER- and PR-positive group (p = 0.0038, p = 0.0071). ER- or PR-negative subgroup showed worse prognosis than ER- and PR-positive subgroup in the luminal B HER2-negative group. We could consider the negativity of ER or PR as prognostic marker in luminal B HER2-negative subtype of breast cancer.